A.) 50.45m + 60 = 57.95m
b.) 50.45m + 60 = 57.95m
60 = 57.95m - 50.45m
60 = 7.50m
60 / 7.50 = m
8 = m.....so the cost will be the same at 8 months
Monthly payments, P = {R/12*A}/{1- (1+R/12)^-12n}
Where R = APR = 4.4% = 0.044, A = Amount borrowed = $60,000, n = Time the loan will be repaid
For 20 years, n = 20 years
P1 = {0.044/12*60000}/{1- (1+0.044/12)^-12*20} = $376.36
Total amount to be paid in 20 years, A1 = 376.36*20*12 = $90,326.30
For 3 years early, n = 17 year
P2 = {0.044/12*60,000}/{1-(1+0.044/12)^-12*17} = $418.22
Total amount to be paid in 17 years, A2 = 418.22*17*12 = $85,316.98
The saving when the loan is paid off 3 year early = A1-A2 = 90,326.30 - 85,316.98 = $5,009.32
Therefore, the approximate amount of savings is A. $4,516.32. This value is lower than the one calculated since the time of repaying the loan does not change. After 17 years, the borrower only clears the remaining amount of the principle amount.
Answer:
The domain of the function (cd)(x) will be all real values of x except x = 2.
Step-by-step explanation:
The two functions are 
and d(x) = x + 3
So, (cd)(x) = 
Then, for x = 2 the function (cd)(x) will be undefined as zero in the denominator will make the function (cd)(x) undefined.
Therefore, the domain of the function (cd)(x) will be all real values of x except x = 2. (Answer)
In 1944 Elion joined the Burroughs Wellcome Laboratories (now part of GlaxoSmithKline (a company that makes prescription medicines)). There she was first the assistant and then the colleague of Hitchings, with whom she worked for the next four decades. Elion and Hitchings developed an array (variety) of new drugs that were effective against leukemia, autoimmune disorders, urinary-tract infections, gout, malaria, and viral herpes. Their success was due primarily to their innovative (characterized by new or unique) research methods. Rather than using the trial-and-error approach used by previous pharmacologists, Elion and Hitchings examined the difference between the biochemistry of normal human cells and that of cancer cells, bacteria, viruses, and other pathogens (disease-causing agents). They used this information to create drugs that could target a particular pathogen without harming the human host's normal cells. Their methods enabled them to eliminate much of the guesswork and wasted effort typical in previous drug research.
